Back

Clinical and electrophysiological effects of cathodal HD-tDCS to the right STS in psychosis spectrum disorders: A pilot proof of concept study

Trotti, R. L.; Raymond, N.; Parker, D. A.; Turkozer, H. B.; Patel, P.; Stiltner, B.; Ying, D.; Molho, W.; Reinhart, R. M. G.; Keshavan, M.; Lizano, P.

2026-01-22 psychiatry and clinical psychology
10.64898/2026.01.21.26344308
Show abstract

The right superior temporal sulcus (rSTS) plays a causal role in multisensory hallucinations, is associated with audiovisual integration (AVI), and displays abnormal activity in psychotic disorders. We sought to reduce psychosis symptoms including hallucinations while modulating AVI and rSTS activity with cathodal, high-definition transcranial direct current stimulation (HD-tDCS) of the rSTS. This double-blind, randomized, sham-controlled pilot study applied HD-tDCS to the rSTS using a ring montage (-1.5 mA cathode center and three .5 mA anode surrounds). Stimulation was administered (N=6 active, N=6 sham) for 5 days with 2 20-minute sessions per day. Assessments occurred at baseline, 5-day, and 1-month timepoints. Electroencephalography (EEG) was recorded during resting state and an AVI steady state (SSR) paradigm. Given the pilot nature of this study, analyses used an alpha threshold of .10. The active group demonstrated reduced clinician-assessed symptoms at 5-days and 1-month, attenuated AVI at 5-days, enhanced auditory SSR and attenuated alpha power over the rSTS at 1-month, and reduced self-reported symptoms at 5-days. Symptom changes correlated with alpha changes. Biological motion, functioning, mood, and cognition did not significantly change. Findings suggest therapeutic effects and successful target engagement. Results provide preliminary proof-of-concept evidence supporting the initiation of a larger trial in psychotic disorders.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Translational Psychiatry
based on 94 papers
Top 1%
12.2%
2
Brain Stimulation
based on 27 papers
Top 0.4%
6.2%
3
Schizophrenia Bulletin
based on 21 papers
Top 0.7%
6.2%
4
Neuropsychopharmacology
based on 29 papers
Top 0.4%
6.2%
5
Biological Psychiatry
based on 36 papers
Top 1%
5.7%
6
Frontiers in Psychiatry
based on 56 papers
Top 1%
5.7%
7
Psychological Medicine
based on 52 papers
Top 2%
5.2%
8
Schizophrenia
based on 13 papers
Top 0.3%
5.2%
50% of probability mass above
9
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
based on 27 papers
Top 0.7%
4.9%
10
Molecular Psychiatry
based on 84 papers
Top 2%
4.4%
11
NeuroImage: Clinical
based on 77 papers
Top 4%
2.9%
12
Psychiatry Research
based on 33 papers
Top 2%
2.9%
13
Schizophrenia Research
based on 11 papers
Top 0.5%
2.7%
14
Journal of Psychiatric Research
based on 22 papers
Top 0.6%
2.7%
15
PLOS ONE
based on 1737 papers
Top 81%
2.7%
16
Journal of Affective Disorders
based on 72 papers
Top 4%
1.5%
17
Scientific Reports
based on 701 papers
Top 73%
1.5%
18
Brain Communications
based on 79 papers
Top 6%
1.3%
19
Frontiers in Neurology
based on 74 papers
Top 10%
1.3%
20
JAMA Psychiatry
based on 11 papers
Top 0.6%
1.3%
21
The British Journal of Psychiatry
based on 21 papers
Top 3%
0.8%
22
European Neuropsychopharmacology
based on 11 papers
Top 2%
0.8%
23
Biological Psychiatry Global Open Science
based on 23 papers
Top 4%
0.7%
24
Progress in Neuro-Psychopharmacology and Biological Psychiatry
based on 10 papers
Top 1%
0.7%